RSV is a common respiratory virus, which usually causes mild cold-like symptoms. Most people recover within one to two weeks, but RSV it can be serious in vulnerable people, including older adults and people with lung or heart disease and diabetes. The singer and presenter spoke about the terrible experience with this virus Thomas Puskailer (44).
“For the first time in our lives, we heard what the RSV virus is. I don’t want any parent to go through what we went through.” said the former superstar whose the daughter fought for her life shortly after birth.
The actor has sons Noah, Jesse and daughter Daisy. “We immediately took her to the hospital. The condition worsened and she had to go on pulmonary ventilation. We just watched, they gave her tubes and put Daisy to artificial sleep. All this happened within 24 hours. Then came the blank – she was on ventilation, in artificial sleep, and we prayed every day that she would survive.” described several days of horror in a broken voice and with tears in his eyes, the father of three. You can find the VIDEO from the report at the end of the article.
The European Commission announced in August 2023 that it had authorized the first vaccine to protect infants against respiratory syncytial virus (RSV) infections. The Commission specified that it has approved the use of the Abrysvo vaccine in the single European market, the first to protect older adults and also infants up to six months against lower respiratory tract disease caused by the respiratory syncytial virus.
The vaccine, which is now authorized across the EU, will help boost the immune response to the virus. The European Commission’s authorization followed a rigorous evaluation under the accelerated evaluation mechanism of the European Medicines Agency. Given that prevention of RSV infection in children is a major public health concern, the EC accelerated the approval of the vaccine.
